Our portfolio company, LUNAPHORE, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, raised CHF 23M in a Series C funding round.
The round was led by global healthcare company PHC Holding Corporation that owns Epredia, a leading provider of comprehensive solution for precision cancer diagnostics. Alpana Ventures and other co-investors participated in this financing round.
LUNAPHORE will invest the proceeds in market and product expansion.
Alpana congratulates LUNAPHORE’s team for this achievement.
FOLLOW ALPANA NEWS:
SWITZERLAND
Tour de l’Ile 1
CH – 1204 Geneva
+41 22 312 20 50
SILICON VALLEY, USA
Via Regina
Saratoga CA 95070
+1 408 644 8104
Copyright 2021 by ALPANA VENTURES